ATE270096T1 - Glukose enthaltende zubereitung - Google Patents

Glukose enthaltende zubereitung

Info

Publication number
ATE270096T1
ATE270096T1 AT98938896T AT98938896T ATE270096T1 AT E270096 T1 ATE270096 T1 AT E270096T1 AT 98938896 T AT98938896 T AT 98938896T AT 98938896 T AT98938896 T AT 98938896T AT E270096 T1 ATE270096 T1 AT E270096T1
Authority
AT
Austria
Prior art keywords
solution
glucose
value
preparation
preparation containing
Prior art date
Application number
AT98938896T
Other languages
English (en)
Inventor
Takumi Kikuchi
Kouichi Hirano
Original Assignee
Shimizu Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17056409&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE270096(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shimizu Pharma filed Critical Shimizu Pharma
Application granted granted Critical
Publication of ATE270096T1 publication Critical patent/ATE270096T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/282—Operational modes

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98938896T 1997-08-22 1998-08-19 Glukose enthaltende zubereitung ATE270096T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24023197 1997-08-22
PCT/JP1998/003674 WO1999009953A1 (fr) 1997-08-22 1998-08-19 Preparation contenant du glucose

Publications (1)

Publication Number Publication Date
ATE270096T1 true ATE270096T1 (de) 2004-07-15

Family

ID=17056409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98938896T ATE270096T1 (de) 1997-08-22 1998-08-19 Glukose enthaltende zubereitung

Country Status (12)

Country Link
US (1) US6399110B1 (de)
EP (1) EP1008341B1 (de)
JP (1) JP3684435B2 (de)
KR (1) KR100384188B1 (de)
CN (1) CN1152668C (de)
AT (1) ATE270096T1 (de)
AU (1) AU740613B2 (de)
CA (1) CA2301577C (de)
DE (1) DE69824861T2 (de)
HK (1) HK1028336A1 (de)
TW (1) TWI224007B (de)
WO (1) WO1999009953A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9506021A (pt) 1994-07-01 1997-10-14 Baxter Int Solução de diálise peritoneal e processo para corrigir a acidose metabólica
DE19748290B8 (de) * 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
DE19912850B4 (de) 1999-03-22 2005-04-07 Fresenius Medical Care Deutschland Gmbh Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung
US7186420B2 (en) 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US6743191B1 (en) 1999-04-26 2004-06-01 Edwards Lifesciences Ag Substitution infusion fluid and citrate anticoagulation
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
JP5204359B2 (ja) * 2001-09-28 2013-06-05 味の素株式会社 透析用剤およびその製造方法
US7122210B2 (en) 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
DE10217356B4 (de) * 2002-04-18 2012-03-29 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
RU2353400C2 (ru) * 2002-11-21 2009-04-27 Кова Ко., Лтд. Способ перитонеального диализа
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
SE0301577L (sv) * 2003-05-28 2004-11-29 Gambro Lundia Ab Lösning med låg natriumhalt
US7053059B2 (en) * 2003-07-25 2006-05-30 Baxter International Inc. Dialysis solutions with reduced levels of glucose degradation products
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
US7935070B2 (en) * 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
JP5371278B2 (ja) * 2008-04-03 2013-12-18 エイワイファーマ株式会社 透析用剤およびその製造方法
KR100993178B1 (ko) 2009-05-19 2010-11-10 제이에스엠헬스케어 주식회사 구연산이 함유된 저농도 초산의 인공신장관류액
US8438898B2 (en) * 2009-07-01 2013-05-14 Edwards Lifesciences Corporation Calibrant infusion fluid source preparation
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
CN103316038B (zh) * 2012-03-20 2016-01-20 胡森 用于治疗循环血容量不足或失水伴失盐的丙酮酸钠（Pyruvate）口服补液盐组合物
CN102793720A (zh) * 2012-08-17 2012-11-28 江苏正大丰海制药有限公司 一种用于解决混合糖电解质注射液灭菌后析出结晶物的方法
JP5376480B1 (ja) * 2012-10-10 2013-12-25 富田製薬株式会社 酢酸及び酢酸塩を含む透析用ａ剤、及びそれを用いた２剤型透析用剤
JPWO2014083612A1 (ja) 2012-11-27 2017-01-05 テルモ株式会社 腹膜透析液
CN104619347B (zh) * 2012-11-27 2018-08-03 泰尔茂株式会社 腹膜透析液
JP5517322B1 (ja) * 2013-10-02 2014-06-11 富田製薬株式会社 酢酸及び酢酸塩を含む３剤型透析用剤
JP5517321B1 (ja) 2013-10-02 2014-06-11 富田製薬株式会社 二酢酸アルカリ金属塩を含む固形透析用ａ剤、及びそれを用いた２剤型の低酢酸透析用剤
KR20230058544A (ko) * 2015-08-18 2023-05-03 아스텔라스 인스티튜트 포 리제너러티브 메디슨 임상 제제
PL3452139T3 (pl) * 2016-05-06 2024-02-19 Gambro Lundia Ab Układ do dozowania płynów
CN109481459B (zh) * 2018-11-23 2021-07-20 济南康和医药科技有限公司 一种复方电解质葡萄糖注射液及其制备方法
CN110227079B (zh) * 2019-06-04 2022-07-26 延边大学草仙药业有限公司 一种五维赖氨酸颗粒及其制备方法
WO2022081929A1 (en) * 2020-10-15 2022-04-21 American Insect Attractants Llc Compositions and methods for attracting insects
US11925703B1 (en) * 2022-07-29 2024-03-12 Xellia Pharmaceuticals Aps Liquid composition comprising glucose

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
JPH03195561A (ja) * 1989-12-26 1991-08-27 Nippon Medical Supply Corp グルコース含有蒸気滅菌液の製造法およびそれに使用する用具
JPH07500026A (ja) 1991-07-12 1995-01-05 ダブリュ．エル．ゴア　アンド　アソシエーツ，インコーポレイティド 防水性履物
DE4125819A1 (de) * 1991-08-03 1993-02-04 Rolf Prof Dr Med Zander Waessrige loesung und deren verwendung
JPH05105633A (ja) 1991-10-14 1993-04-27 Shimizu Seiyaku Kk ブドウ糖製剤及びその製造方法
SE9103395D0 (sv) * 1991-11-18 1991-11-18 Gambro Ab System med anvaendning av ensteril medicinsk loesning innehaallande glukos eller glukosliknande aemnen samt en loesning avsedd foer detta system
EP0564672B2 (de) 1992-04-06 1999-05-06 Baxter International Inc. Wässrige Peritonealdialyse-Lösung
JP3530235B2 (ja) * 1994-09-27 2004-05-24 味の素ファルマ株式会社 血液透析用剤
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
JPH0987182A (ja) * 1995-09-27 1997-03-31 Terumo Corp 中性腹膜透析液
JP3623294B2 (ja) * 1995-11-28 2005-02-23 株式会社新素材総合研究所 電解質液が収容された医療用容器及びその製造方法

Also Published As

Publication number Publication date
CA2301577A1 (en) 1999-03-04
DE69824861T2 (de) 2005-06-30
US6399110B1 (en) 2002-06-04
AU740613B2 (en) 2001-11-08
KR100384188B1 (ko) 2003-06-18
EP1008341B1 (de) 2004-06-30
KR20010023180A (ko) 2001-03-26
HK1028336A1 (en) 2001-02-16
CA2301577C (en) 2006-12-19
TWI224007B (en) 2004-11-21
EP1008341A1 (de) 2000-06-14
DE69824861D1 (de) 2004-08-05
JP3684435B2 (ja) 2005-08-17
EP1008341A4 (de) 2000-10-18
AU8747398A (en) 1999-03-16
WO1999009953A1 (fr) 1999-03-04
CN1152668C (zh) 2004-06-09
CN1276717A (zh) 2000-12-13

Similar Documents

Publication Publication Date Title
ATE270096T1 (de) Glukose enthaltende zubereitung
EP0176094B1 (de) Parenterale Nährlösung
ATE86862T1 (de) Glukosefreie medien zur lagerung von blutplaettchen.
ATE294597T1 (de) Lösung für die peritonealdialyse
SE8701500L (sv) Lagringsstabilt koncentrat
TR199500780A2 (tr) Biyokimyasal olarak dengelenmis peritonal diyaliz solüsyonlari.
DE69314027D1 (de) Essbare plastische dispersion auf basis von schnell gelierender stärke
SE8505048D0 (sv) Nutritionsemulsion med syretransporterande egenskaper
SE9600631D0 (sv) Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
FI843286A0 (fi) Stabil, sur vattenloesning av cis-platina laemplig foer injektion.
AU1732288A (en) A process for the preparation of a solution of high concentration of a protein having tissue plasminogen activator (t-pa) activity, a solution containing protein having t-pa activity and the use of the solution in human and veterinary medicine
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
Adams et al. Drug interaction in psoriasis.
Benesch et al. Chemical modifications that inhibit gelation of sickle hemoglobin
CA2067371A1 (en) Stable hemoglobin based composition and method to store same
US4422945A (en) Stabilization of pleuromutilin derivatives against oxidation by sodium hypochlorite in aqueous solution
JPS56128711A (en) Glucose-electrolyte preparation for high-calorie transfusion
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
KR900018013A (ko) 시아노아세트아미드 유도체, 그의 제조방법 및 그를 유효 성분으로서 함유하는 식물 병해 방제제
ATE65887T1 (de) Fitness-getraenkepulver
KR880000094A (ko) 위염치료제
ATE360429T1 (de) Krebsmittel
Nanninga Effect of Heat on the Kinetic Constants of Myosin–Adenosine Triphosphatase
Hanning The Effectiveness and Metabolic Consequences of the Use of Amino Acid Versus Glucose Based Dialysis Solutions in Infants and Children Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD)
Snively Jr et al. In the balance

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties